乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

WCN

<乌鸦传媒 class="page-description">World Congress of Neurology
Data Supports Eslicarbazepine in Epilepsy

VIENNA -- Pooled phase III study results on eslicarbazepine acetate, a prodrug for S(+)-liscarbazepine, showed that the drug outperformed placebo as add-on therapy for partial-onset seizures in adults, a researcher said here.

image
<乌鸦传媒 class="section_title">Latest WCN Meeting Coverage
<乌鸦传媒 class="section_title"> Latest Neurology Meeting Coverage